Events / Women in COG

24 Aug 2022

Women in COG: in Conversation with Dr Mariana Viegas

On Thursday 10th November, at 13:15 – 14:00 GMT, we will be hosting our ‘Women in COG’ event featuring Dr Mariana Viegas, professor of clinical virology  at the Faculty of Exact Sciences of the Universidad Nacional de La Plata (UNLP), Argentina, and coordinator of the Argentine Consortium for SARS-CoV-2 Genomics (PAIS project).

This event will feature a conversation with Mariana followed by an informal Q&A.


When? 10th November 13:15h
Where? Virtual
Who can attend? Everyone


Dr Mariana Viegas

Mariana Viegas is a biochemist and has a PhD from the Faculty of Exact Sciences of the Universidad Nacional de La Plata (UNLP). She is a professor of clinical virology at that faculty since 2006. Mariana has been working on viral evolution studies of respiratory viruses in paediatric patients at the Virology Laboratory of the Ricardo Gutiérrez Children’s Hospital (HNRG) in Buenos Aires, Argentina since 1999, where she is currently an independent CONICET researcher. She has collaborated as an External Advisor to the World Health Organization since 2019 within the WHO Global Respiratory Syncytial Virus (RSV) Surveillance program. In 2013, Mariana ventured into Next Generation Sequencing technologies to begin with the genomic approach in her work. Since 2015, her team developed and implemented a genomic surveillance of RSV in paediatrics at their hospital. Then, they expanded their experience into the genomic studies of other respiratory viruses and new approaches, such as metagenomics. Due to her previous experience, she was the right person to brainstorm, create, and coordinate the Argentine Consortium for SARS-CoV-2 Genomics (PAIS project).


COVID-19 Genomics UK (COG-UK)

The COVID-19 Genomics UK (COG-UK) consortium works in partnership to harness the power of SARS-CoV-2 genomics in the fight against COVID-19.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative collaboration of NHS organisations, the four public health agencies of the UK, the Wellcome Sanger Institute and sixteen academic partners. A full list of collaborators can be found here.

The COVID-19 pandemic, caused by SARS-CoV-2, represents a major threat to health. The COG-UK consortium was formed in March 2020 to deliver SARS-CoV-2 genome sequencing and analysis to inform public health policy and to support the establishment of a national pathogen sequencing service, with sequence data now predominantly generated by the Wellcome Sanger Institute and the Public Health Agencies.

SARS-CoV-2 genome sequencing and analysis plays a key role in the COVID-19 public health response by enabling the identification, tracking and analysis of variants of concern, and by informing the design of vaccines and therapeutics. COG-UK works collaboratively to deliver world-class research on pathogen sequencing and analysis, maximise the value of genomic data by ensuring fair access and data linkage, and provide a training programme to enable equity in global sequencing.